RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats-Reference-Cited by-同舟云学术

RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats

Published:2008-02-04 Issue:5 Volume:23 Page:672-682
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Ominsky Michael S,Li Xiaodong,Asuncion Frank J,Barrero Mauricio,Warmington Kelly S,Dwyer Denise,Stolina Marina,Geng Zhaopo,Grisanti Mario,Tan Hong-Lin,Corbin Timothy,McCabe James,Simonet William S,Ke Hua Z,Kostenuik Paul J

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts;Burgess;J Cell Biol,1999

2. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation;Lacey;Cell,1998

3. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo;Lacey;Am J Pathol,2000

4. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand;Hsu;Proc Natl Acad Sci USA,1999

5. RANK is essential for osteoclast and lymph node development;Dougall;Genes Dev,1999

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes;Science Advances;2023-11-03

2. 5′-Methylthioadenosine strongly suppresses RANKL-induced osteoclast differentiation and function via inhibition of RANK-NFATc1 signalling pathways;Heliyon;2023-11

3. Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics;Cancers;2023-08-07

4. Denosumab's Therapeutic Effect for Future Osteosarcopenia Therapy : A Systematic Review and Meta-Analysis;Annals of Geriatric Medicine and Research;2023-03-31

5. Denosumab prevented periprosthetic bone resorption better than risedronate after total hip arthroplasty;Journal of Bone and Mineral Metabolism;2023-02-06